End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.35 USD | -2.89% | -0.42% | -60.17% |
Business Summary
Number of employees: 1,525
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Patient Service
98.9
%
| 1,138 | 99.0 % | 1,266 | 98.9 % | +11.23% |
Other
1.1
%
| 12 | 1.0 % | 13 | 1.1 % | +14.72% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1,150 | 100.0 % | 1,279 | 100.0 % | +11.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Schonherz
CEO | Chief Executive Officer | 54 | 19/09/23 |
David Afshar
DFI | Director of Finance/CFO | 52 | 05-16 |
Stephen Divers
CTO | Chief Tech/Sci/R&D Officer | 51 | 19/09/23 |
Erica Mallon
LAW | General Counsel | - | 19/09/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bradley Fluegel
BRD | Director/Board Member | 62 | 19/09/23 |
James Stith
BRD | Director/Board Member | 40 | 19/09/23 |
Todd Schonherz
CEO | Chief Executive Officer | 54 | 19/09/23 |
Ravi Sarin
BRD | Director/Board Member | 42 | 19/09/23 |
Stephen Divers
CTO | Chief Tech/Sci/R&D Officer | 51 | 19/09/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,725,998 | 0 | 0 | 58.29 % |
Stock B | 1 | 13,077,512 | 7,623,286 ( 58.29 %) | 31,170 ( 0.2383 %) | |
Stock C | 0 | 6,651,610 | 0 | 0 |
Company contact information
American Oncology Network, Inc.
14543 Global Parkway Suite 110
33913, Fort Myers
+
http://www.aoncology.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-60.17% | 23.99M | |
+22.65% | 86.96B | |
-23.68% | 75.65B | |
+0.63% | 26.97B | |
+6.13% | 17.89B | |
-13.47% | 16.58B | |
+2.68% | 15.73B | |
+69.13% | 13.01B | |
+74.99% | 12.92B | |
+4.03% | 12.5B |
- Stock Market
- Equities
- AONC Stock
- Company American Oncology Network, Inc.